Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
JAMA Oncology · 01.04.2023 · 9 (4) · 465
DOI: 10.1001/jamaoncol.2022.7826 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Oncology, erschienen am 01.04.2023. Verfasst von Simiao Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 916-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Importance Cancers are a leading cause of mortality, accounting for nearly 10 million annual deaths worldwide, or 1 in 6 deaths. Cancers also negatively affect countries’ economic growth. However, the global economic cost of cancers and its worldwide distribution have yet to be studied.
Objective
To estimate and project the economic cost of 29 cancers in 204 countries and territories. Design, Setting, and Participants A decision analytical model that incorporates economic feedback in assessing health outcomes associated with the labor force and investment. A macroeconomic model was used to account for (1) the association of cancer-related mortality and morbidity with labor supply; (2) age-sex-specific differences in education, experience, and labor market participation of those who are affected by cancers; and (3) the diversion of cancer treatment expenses from savings and investments. Data were collected on April 25, 2022. Main Outcomes and Measures Economic cost of 29 cancers across countries and territories. Costs are presented in international dollars at constant 2017 prices.
Results
The estimated global economic cost of cancers from 2020 to 2050 is $25.2 trillion in international dollars (at constant 2017 prices), equivalent to an annual tax of 0.55% on global gross domestic product. The 5 cancers with the highest economic costs are tracheal, bronchus, and lung cancer (15.4%); colon and rectum cancer (10.9%); breast cancer (7.7%); liver cancer (6.5%); and leukemia (6.3%). China and the US face the largest economic costs of cancers in absolute terms, accounting for 24.1% and 20.8% of the total global burden, respectively. Although 75.1% of cancer deaths occur in low- and middle-income countries, their share of the economic cost of cancers is lower at 49.5%. The relative contribution of treatment costs to the total economic cost of cancers is greater in high-income countries than in low-income countries. Conclusions and Relevance In this decision analytical modeling study, the macroeconomic cost of cancers was found to be substantial and distributed heterogeneously across cancer types, countries, and world regions. The findings suggest that global efforts to curb the ongoing burden of cancers are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Institute for Artificial Intelligence, Tsinghua University, Beijing, China.
- State Key Lab of Intelligent Technologies and Systems, Beijing National Research Center for Information Science and Technology, Department of Automation, Tsinghua University, Beijing, China.
- Vienna Institute of Demography, Wittgenstein Centre, International Institute for Applied Systems Analysis, OeAW, University of Vienna, Vienna, Austria.
- Vienna University of Economics and Business (WU), Department of Economics, Vienna, Austria.
Förderung
- NIA NIH HHS
Zitieren
APA
Chen, S., Cao, Z., Prettner, K., Kuhn, M., Yang, J., Jiao, L., Wang, Z., Li, W., Geldsetzer, P., Bärnighausen, T., Bloom, D. E., & Wang, C. (2023). Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncology, 9(4), 465. https://doi.org/10.1001/jamaoncol.2022.7826
Vancouver
Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncology. 2023;9(4):465. doi:10.1001/jamaoncol.2022.7826
BibTeX
@article{Chen2023,
author = {Chen, Simiao and Cao, Zhong and Prettner, Klaus and Kuhn, Michael and Yang, Juntao and Jiao, Lirui and Wang, Zhuoran and Li, Weimin and Geldsetzer, Pascal and Bärnighausen, Till and Bloom, David E and Wang, Chen},
title = {Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050},
journal = {JAMA Oncology},
year = {2023},
volume = {9},
number = {4},
pages = {465},
doi = {10.1001/jamaoncol.2022.7826}
}
EUVIMED